TrialResults-center.org

Menu

Description Results NMA

Group by...

in first

in second

in third

pdf

pathology

Demonstrated benefit and harm

k

advanced breast cancer (metastatic)

versus CT alone

No demonstrated result for efficacy

Trial	control	p<0.05	harm	NS
	T1 vs T0
	T1 vs T0
	T1 vs T0

Trial

Treatments

Patients

Method

Abe, 1995

(n=-9)

vs.

(n=-9)

Sample size: -9/-9

Primary endpoint:

FU duration:

Tominaga, 1994

(n=-9)

vs.

(n=-9)

Sample size: -9/-9

Primary endpoint:

FU duration:

Gundersen, 1992

(n=-9)

vs.

(n=-9)

Sample size: -9/-9

Primary endpoint:

FU duration:

Modal title

- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy -